Placebo intranasal spray

DRUG4 trials

Sponsors

University of Dundee, Pherin Pharmaceuticals, Inc., Tehran University of Medical Sciences, George Washington University

Conditions

Allergic RhinitisAsthmaPainPremenstrual Dysphoric DisorderRenal ColicSleep Apnea, Obstructive

Phase 2

Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep

CompletedNCT03148899

George Washington UniversitySleep Apnea, Obstructive

Start: 2016-07-27End: 2020-06-07Updated: 2023-01-31

Phase 3

Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder

Pherin Pharmaceuticals, Inc.Premenstrual Dysphoric Disorder

Start: 2016-03-31End: 2017-07-31Target: 1400Updated: 2015-12-03

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

Tehran University of Medical SciencesPain, Renal Colic

Start: 2012-03-31End: 2013-03-31Target: 88Updated: 2012-12-05

Phase 4

Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis

CompletedNCT00903227

University of DundeeAllergic Rhinitis, Asthma

Start: 2006-12-31End: 2008-08-31Updated: 2019-10-16

Related Papers

Intranasal oxytocin increases respiratory rate and reduces obstructive event duration and oxygen desaturation in obstructive sleep apnea patients: a randomized double blinded placebo controlled study.

2020-06-0524 citations